Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma

Histology and Histopathology

Volumn 19, Issue 2, 2004, Pages 401-411

  Ragazzini, Paolo ^a   Gamberi, G ^a   Pazzaglia, L ^a   Serra, M ^a   Magagnoli, G ^a   Ponticelli, F ^a   Ferrari, C ^a   Ghinelli, C ^a   Alberghini, M ^a   Bertoni, F ^a   Picci, P ^a   Benassi, M S ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

CDK4; GLI; Leiomyosarcoma; MDM2; Rhabdomyosarcoma; SAS

Indexed keywords

BETA ACTIN; CYCLIN DEPENDENT KINASE 4; DNA; MEMBRANE PROTEIN; PROTEIN GLI; PROTEIN MDM2; PROTEIN SAS; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ADOLESCENT; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER CLASSIFICATION; CHILD; CHROMOSOME 12Q; CONTROLLED STUDY; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; DNA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LEIOMYOSARCOMA; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NUCLEAR PROTEINS; OLIGONUCLEOTIDES; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SARCOMA; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 11144355696     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. An H-X., Beckmann M.W., Reifenberger G., Bender H.G. and Niederacher D. (1999). Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation. Am. J. Pathol. 154, 113-118.
2. Bale P.M. and Reye R.D. (1975). Rhabdomyosarcoma in childhood. Pathology 7, 101-111.
3. Bell R.S., Wunder J. and Andrulis I. (1999). Molecular alterations in bone and soft-tissue sarcoma. Can. J. Surg. 42, 259-266.
4. Berner J.M., Forus A., Elkahloun A., Meltzer P.S., Fodstad O. and Myklebost O. (1996). Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosomes Cancer 17, 254-259.
5. Bridge J.A., Liu J., Qualman S.J., Suijkerbuijk R., Wenger G., Zhang J., Wan X., Baker K.S., Sorensen P. and Barr F. (2002). Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer 33, 310-321.
6. Bridge J.A., Liu J., Weibolt V., Baker K.S., Perry D., Kruger R., Qualman S., Barr F., Sorensen P., Triche T. and Suijkerbuijk R. (2000). Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization: An intergroup rhabdomyosarcoma study. Genes Chromosomes Cancer 27, 337-344.
7. Campanacci M. (1999). Bone and soft ttssue tumors. 2nd edition. Piccin Nuova Libreria, Padova and Springer Verlag, Wien, New-York.
8. Cordon-Cardo C., Latres E., Drobnjak M., Oliva M.R., Pollack D., Woodruff J.M., Marechal V., Chen J., Brennan M.F. and Levine A.J. (1994). Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res. 54, 794-799.
9. Crist W.M., Garnsey L., Beltangady M.S., Gehan E., Ruymann F., Webber B., Hays D.M., Wharam M. and Maurer H.M. (1990). Prognosis in children with rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma studies I and II - Intergroup rhabdomyosarcoma commitee. J. Clin. Oncol. 8, 443-452.
10. Elkahloun A.G., Bittner M., Hoskins K., Gemmill R. and Meltzer P.S. (1996). Molecular cytogenetic characterization and physical mapping of 12q13-15 amplification in human cancer. Genes Chromosomes Cancer 17, 205-214.
11. Forus A., Florenes V.A., Maelandsmo G.M., Meltzer P.S., Fodstad O. and Myklebost O. (1993). Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: Some amplica do not include MDM2. Cell. Growth. Differ. 4, 1065-1070.
12. Gordon A.T., Brinkschmidt C., Anderson J., Coleman N., Dockhorn-Dworniczak B., Pritchard-Jones K. and Shipley J. (2000). A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 28, 220-226.
13. Jankowski S.A., Mitchell D.S., Smith H.S., Trent J.M. and Meltzer P.S. (1994). SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins. Oncogene 9, 1205-1211.
14. Khatib Z.A., Matsushime H., Valentine M., Shapiro D.N., Sherr C.J. and Look A.T. (1993). Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res. 53, 5535-5541.
15. Kinzler K., Bigner S., Bigner D., Trent J., Law M., O'Brien S., Wong A. and Vogelstein B. (1987). Identification of an amplified higly expressed gene in human glioma. Science 236, 70-73.
16. Kinzler K.W., Ruppert J.M., Bigner S.H. and Vogelstein B. (1988). The gli gene is a member of the Kruppel family of zinc finger proteins. Nature 332, 371-374.
17. Kodet R., Newton W.A., Hamoudi A., Asmar L., Jacobs D.L. and Maurer H.M. (1993). Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features: A report of the intergroup rhabdomyosarcoma study. Am. J. Surg. Pathol. 17, 443-453.
18. Ladanyi M., Cha C., Lewis R., Jhanwar S.C., Huvos A.G. and Healey J.H. (1993). MDM2 amplification in metastatic osteosarcoma. Cancer Res. 53, 16-18.
19. Lehmann U., Glockner S., Kleeberger W., Feist H., von Wasielewski R. and Kreipe H. (2000). Detection of gene amplification in archivial breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. Am. J. Pathol. 156, 1855-1864.
20. Matsushime H., Ewen M.E., Strom D.K., Kato J.Y., Hanks S.K., Roussel M.F. and Sherr C.J. (1992). Identification and properties of an atypical subunit (p34 psk-j3/cdk4) for mammalian D type G1 cyclins. Cell 71, 323-334.
21. Meltzer P.M., Jankowski S.A., Dal Cin P., Sandberg A.A., Paz I.B. and Coccia M.A. (1991). Identification and cloning of a novel amplified DNA sequence in human malignant fibrous histiocytoma derived from a region of chromosome 12 frequently rearranged in soft tissue tumors. Cell Growth Differ. 2, 495-501.
22. Momand J., Zambetti G.P., Olson D.C., George D. and Levine A.J. (1992). The mdm-2 oncogene product forms a complex with p53 mediated transactivation. Cell 69, 1237-1245.
23. Nakayama T., Toguchida J., Wadayama B., Kanoe H., Kotoura Y. and Sasaki M.S. (1995). MDM2 gene amplification in bone and soft-tissue tumors: Association with tumor progression in differentiated adipose tissue tumors. Int. J. Cancer 64, 342-346.
24. Newton W.A.J., Gehan E.A., Webber B.L., Marsden H.B., van Unnik A.J., Hamoudi A.B., Tsokos M.G., Shimada H., Harms D., Schmidt D., Ninfo V., Cavazzana A.O., Gonzalez-Crussi F., Parham D.M., Reiman H.M., Asmar L., Beltangedy M.S., Sachs N.E., Triche T.J. and Maurer H.M. (1995). Classification of rhabdomyosarcomas and related sarcomas: pathologic aspects and proposal for a new classification-an Intergroup Rhabdomyosarcoma Study. Cancer 76, 1073-1085.
25. Nilbert M., Rydholm A., Mitelman F., Meltzer P.S. and Mandahl N. (1995). Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet. Cytogenet. 83, 32-36.
26. Oliner J.D., Kinzler K.W., Meltzer P.S., George D.L. and Vogelstein B. (1992). Amplification of gene encoding a p53-associated protein in human sarcomas. Nature 358, 80-83.
27. Oliveira A.M. and Nascimento A.G. (2001). Grading in soft tissue tumors: Principles and problems. Skeletal Radiol. 30, 543-559.
28. Orlando C., Pinzani P. and Pazzagli M. (1998). Developments in quantitative PCR. Clin. Chem. Lab. Med. 36, 255-269.
29. Pandita A., Zielenska M., Thorner P., Bayani J., Godbout R., Greenberg R. and Squire J.A. (1999). Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma. Neoplasia 1, 262-275.
30. Patterson H., Gill S., Fisher C., Law M.G., Jayatilake H., Fletcher C.D.M., Thomas M., Grimer R., Gusterson B.A. and Cooper C.S. (1994). Abnormalities of the p53, MDM2, and DCC genes in human leiomyosarcomas. Br. J. Cancer 69, 1052-1058.
31. Phelan J.T., Sherer W. and Mesa P. (1962). Malignant smooth muscle tumors (leiomyosarcomas) of soft tissue origin. N. Engl. J. Med. 266, 1027-1030.
32. Reifenberger G., Ichimura K., Reifenberger J., Elkahloun A.G., Meltzer P.S. and Collins V.P. (1996). Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggest CDK4/SAS and MDM2 as independent amplification targets. Cancer Res. 56, 5141-5145.
33. Roberts M., Douglass E., Peiper S., Houghton P. and Look T. (1989). Amplification of the gli gene in childhood sarcomas. Cancer Res. 49, 5535-5541.
34. Ruppert J.M., Vogelstein B. and Kinzler K.W. (1991). The zinc finger protein GLI transforms primary cells in cooperation with adenovirus E1A. Mol. Cell. Biol. 11, 1724-1728.
35. Sambrook J., Fritsch E.F. and Maniatis T. (1989). Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press. NewYork.
36. Sherr C.J. (1993). Mammalian G1 cyclins. Cell 73, 1059-1065.
37. Smith S.H., Weiss S.W., Jankowski S.A., Coccia M.A. and Meltzer P.S. (1992). SAS amplification in soft tissue sarcomas. Cancer Res. 52, 3746-3749.
38. Stein U., Eder C., Karsten U., Haensch W., Walther W., Schlag P.M. (1999). GLI gene expression in bone and soft tissue sarcomas of adult patients correlates with tumor grade. Cancer Res. 59, 1890-1895.
39. Weber-Hall S., Anderson J., McManus A., Abe S., Nojima T., Pinkerton R., Pritchard-Jones K. and Shipley J. (1996). Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res. 56, 3220-3224.
40. Wunder J.S., Kolja E., Sarah R.B., Nalan G., Robert S.B. and Andrulis I.L. (1999) Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Oncogene 18, 783-788.